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                                     ABSTRACT AND KEYWORDS 
 
BACKGROUND OF STUDY: Magnesium has been implicated in the 
pathogenesis of myocardial infarction and its complication like 
arrhythmia. Magnesium improves myocardial metabolism , inhibits 
calcium accumulation and myocardial cell death. It improves vascular 
tone, peripheral vascular resistance, after load and cardiac output, 
reduces cardiac arrhythmias and improves lipid metabolism. 
Magnesium also reduces vulnerability to oxygen derived free radicals, 
improves endothelial function and inhibits platelet aggregation and 
adhesion. 
OBJECTIVE: To know the relationship between the serum magnesium 
levels and arrhythmias in patients with acute myocardial infarction. 
METHOD:  By using simple random method, 60 cases of acute 
myocardial infarction admitted in THANJAVUR MEDICAL 
COLLEGE HOSPITAL, THANJAVUR over a period of 11 months, 
i.e., between  July  2014 to may 2015. 
RESULTS:  There is significant difference in Magnesium levels in 
patients with and without arrhythmias. 
CONCLUSION:  In acute myocardial infarction, patients with low 
magnesium levels are more prone to get arrhythmias. So magnesium 
treatment can be considered in patients of acute myocardial infarction 
with low magnesium levels. 
KEYWORDS:  Magnesium; Myocardial Infarction ; Arrythmias. 
                                     INTRODUCTION 
 
                      Pasteur  (1860)  showed  that  yeast   will  grow   only  when   the  culture   
medium  contains  inorganic compounds.   In  the human  body there  is  a tendency  to 
maintain  the  proper  fluid  balance,  not  only  as  a  whole but  between  the  three 
compartments  of intracellular,  interstitial and  intravascular  spaces.   This  is maintained  
by  an intricate  play  of  hemodynamic,  electrolyte and  other  forces.    
                      The  field  of mineral metabolism  is  at  present in  a phase of rapid 
expansion.  It has become apparent that  not only  proteins, fats and  carbohydrates, but  
also minerals are essential to life.  Now the  significance of  traces not only of vitamins 
and other active organic substances, but also of minerals is under intensive investigation. 
Magnesium   has   been   implicated    in   the   pathogenesis   of   Acute Myocardial  
Iinfarction  and   its  complications  like  arrhythmias. It  plays  a significant role in  other 
cardiovascular diseases  as well.  Magnesium  ions are considered  essential  for  the  
maintenance  of  the  functional integrity  of  the myocardium. 
                      Myocardial  magnesium  concentration  in  patients  with  sudden  death 
due to ischemic  heart disease was found  to be very low .  It has  been pointed out  that 
magnesium  has a  vital  role in  ventricular fibrillation,  which  causes sudden  death in  
IHD. The coronary  vasospasm  resulting from  magnesium  deficiency has been 
suggested  as another important factor in  the sudden death in  IHD. Magnesium 
deficiency was  also postulated to have  role  in the genesis of atheromatous plaques in 
1
1
1
1 
that it leads to hyperlipidemia. Also myocardial  infarction  is one  of the  common  
causes of  death at  present  where  prognosis  depends   on  multiple  factor  of  which   
many  still remain unexplained.  This  study is designed to know  the relationship 
between serum magnesium  levels and  arrhythmias in  patients with   acute  myocardial 
infarction. 
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AIMS AND OBJECTIVES 
                                        AIMS AND OBJECTIVES 
 
 
To   know   the  relation   between   level   of   serum   magnesium   and arrhythmias in  
patients  with acute  myocardial infarction  who  are presenting within 12 hours of onset 
of symptoms. 
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REVIEW OF LITERATURE 
                                   REVIEW OF LITERATURE 
 
HISTORY REVIEW 
                     Inorganic constituents forms only a small part of human body, yet they are 
very essential for  sustaining  life. It was Liebig (1803-1873) who recognized the 
importance of  minerals as vital parts of plants and animals. The name  ‘Magnesium’  
was given by Sir Humphrey Davy .  It was obtained from the word ‘Magnesia’ which 
was an ancient Gracian town.  Magnesium(mg) was discovered by Joseph Black in 
1755.He distinguished Magnesium oxide (MgO) from Calcium oxide (CaO). 
Meerschaum  (Magnesium Silicate) was found out by Thomas Henry in 1789. French 
scientist Antoine – Alexandre – Brutus - Bussy  reacted magnesium chloride with 
potassium and obtained a sizeable amount of magnesium and carried out many studies on 
Magnesium. 
                      Greenberg described myocardial degeneration with polyplastic infiltration 
and fibroblast proliferation in rats, who were fed on a low magnesium diet. Magnesium is 
an essential component of enzymes involved in oxidative phosphorylation.The 
abnormalities  observed in rats were found to be sequelae to interference of function of 
these magnesium dependant enzymes.[1] 
                       Until middle of Twentieth centuary, isolation and estimation of magnesium 
was difficult and lacked uniformity in procedures. So the studies on magnesium and its 
effects on human body were neglected for long time. But reasonable amount of work on 
4 
significance of magnesium in non primates were available. The availability  of  more 
accurate  uniform methods  for  estimation of serum  magnesium  in  laboratory  gave   
momentum  to  work  on  magnesium metabolism in man. 
                      Only 1%  of total body magnesium  is in the  extra-cellular fluid and  of 
this about 25% is in  the plasma, rest is in the red cells. Around 50% of serum magnesium  
is  free,  32%  is  protein  bound  and  rest  13%  is  accounted  for magnesium phosphate, 
citrate and other unidentified complexes. The vascular space constitutes a minor content 
of  magnesium concentration in the body, so the estimation of plasma concentration of 
,Mg doesnot always impact the actual concentration of Mg in patients , but intracellular 
estimation of Mg levels are under research and not popularly available. (Vermon et al, 
1978)[3]. 
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                                       MAGNESIUM  METABOLISM 
 
                        Manesium is the second most abundant cation in the Intra cellular fluid , 
after Potassium[5] . It ranks fourth among other cations regarding abundance in the 
human body. Magnesium is not uniformly distributed among tissues of human body. 
Magnesium is distributed in Human body according to the metabolic activity of tissues.  
Maximum concentration of magnesium is found in Heart , Kidneys and Brain. Bone 
contains more than 50% of total body Magnesium content and this forms a exchangeable 
source that maintains normal serum magnesium.Only one third of total body bone 
magnesium is in exchangeable form[6]. 
                      Normal human adult body contains 20 – 24 gram of magnesium or 
approximately 2000 milliequivalents(meq) of magnesium. Of this only 1% is found in the 
extracellular fluid.The normal serum magnesium level is found to be 1.8 – 2.9 mg/dl[7]. 
Only 25% of magnesium in extracellular fluid is found in plasma. Of the total plasma 
magnesium about 70% is ultrafilterable. Free form of magnesium constitutes about 
50%.Bound form of plasma magnesium is bound to plasma proteins mainly Albumin. 
Cellular magnesium levels in tissues varies with metabolic activity of tissues.Higher the 
metabolic activity higher the levels of magnesium. The normal cellular magnesium level 
is between  1 – 3 mmol/L[8]. Intracellular  magnesium levels maynot always correlate 
with serum magnesium levels, because only 25% of total extracellular magnesium is 
found in serum[9]. But cellular assays of  Magnesium are not reliable and not widely 
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available. So serum magnesium estimation remains as the best method to evaluate 
magnesium deficiency or magnesium excess. 
 
RENAL MAGNESIUM HANDLING 
                       The  principal  organ involved in the regulation of Magnesium 
Homeostasis is kidney. Every day approximately 8 meq is excreted in urine. During 
periods of Mg deficiency renal conservation of  Mg occurs and it excretes very low 
amount of Mg. But when in states of Mg abundance, kidney excretes more amount of Mg 
to maintain Mg balance in the human body [10]. In humans handling of magnesium by 
kidneys is a filteration – reabsorption process .Micropuncture studies have shown that 
proximal convoluted tubule and thick ascending loop of henle are the major sites of 
magnesium reabsorption. 20 to 30 % of filtered  magnesium is reabsorbed passively in 
the proximal tubules where magnesium reabsorption  follows change in the salt and water 
reabsorption and is associated with the rate of fluid flow. Of the total magnesium filtered 
about 65% is reclaimed in the thick ascending loop of henle by an active transport 
process.  
                    Parathyroid hormone regulates, in part, both calcium and magnesium 
metabolism and excretion. Parathormone  reduces magnesium excretion where as 
aldosterone increase renal excretion of magnesium. Parathormone doesnot have 
important physiological role in the regulation of serum magnesium level as patients with 
both hypoparathyroidism and hyperparathyroidism have normal serum magnesium 
concentration. 
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 MYOCARDIAL MAGNESIUM 
                        Most of the magnesium in human body is found in bone.The adult human 
body contains between 20 and 30 gms of magnesium.Cardiac muscles also has significant 
concentration of magnesium.The higher concentration of magnesium is found in 
ventricles than in atria.There is no significant change in the amount of magnesium 
between right and left ventricles or the interventricular septum[1]. Magnesium was found 
to be involved in the ATP hydrolysis of myofibrils, super-precipitation and sineresis of 
actinomycin gels, and binding and release of calcium ions by sarcotubule reactions, 
which are essential to the contraction of heart muscle.Magnesium activates adenyl 
cyclase, stimulates oxidative phosphorylation in heart mitochondria and affect sodium 
potassium ATPase of heart membranes.Though myocardium is less sensitive than 
nervous tissue to magnesium, it may have influenze in muscle tone and conducting 
system.[5] 
 
MAGNESIUM  ABSORPTION  FROM  INTESTINES. 
                   The minimum recommended daily requirement of magnesium is 300- 500 mg 
. The intestinal absorption is inversely proportional to the amount ingested[11]. The usual 
daily magnesium intake is between 150-350 mg/day. About 50 % of ingested magnesium 
is reabsorbed[12]. The major sources of magnesium are green leafy vegetables ,meat 
,cereals and nuts. 
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Magnesium is absorbed maximally from ileum and  jejnum, though it is absorbed along 
entire intestinal tract. Magnesium is absorbed most efficiently in the chloride form in the 
alkaline environment of small intestine[13]. The existence of an unsuitable passive 
transport system for magnesium absorption may account for the higher fractional 
absorption at low dietary magnesium intake. 
                   A principle factor of hormone controlling intestinal magnesium transport has 
now been described. 25 hydroxy vitamin D and 1,25 dihydroxy vitamin D have been 
found to enhance magnesium absorption by the intestine[14]. Bio availability of 
magnesium may also be a factor in magnesium intestinal absorption. Excessive amounts 
of substances such as free fatty acids, phytates, oxalates, phosphate and fiber may bind 
magnesium and impair absorption[5]. 
 
INTRACELLULAR MAGNESIUM 
                         Magnesium is bound to proteins and negatively charged molecules inside 
the cell. Significant amounts of magnesium are found in the nucleus ,mitochondria and 
endoplasmic reticulum as well as cytoplasm. 80 % of magnesium in the cytoplasm is 
complexed with adenosine triphosphate(ATP)[11]. The concentration of free ionized 
magnesium is about 0.1 mmol/l to 1 mmol/l. It constitutes about 0.55 to 5 % of total 
cellular magnesium. The magnesium concentration in the cell cytoplasm appears to be 
maintained relatively constant. 
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                            PHYSIOLOGICAL ROLE OF MAGNESIUM 
                      
                       It is essential for substrate formation and has direct role in the activation of 
enzymes such as phosphofructokinase, creatinine kinase, adenylate cyclase and sodium-
potassium ATPase[5]. Magnesium plays a role in numerous enzymatic processes in the 
body[5]. Magnesium has important roles in biological processes such as 
glycolysis,oxidative phosphprylation, nucleotide metabolism, protein biosynthesis 
signifies the importance of magnesium in cellular metabolism. 
                     Observation in humans have shown that magnesium deficiency impairs the 
cells ability to maintain potassium gradient resulting in intracellular potassium depletion. 
Magnesium activates the sodium potassium ATPase, which inturn maintain high 
intracellular and low extracellular potassium levels against large concentration gradients. 
The compromised cell membrane cation pump causes loss of cellular potassium and 
accumulation of intracellular sodium. This effect is similar to that which occurs during 
digitalis therapy and may explain why magnesium deficiency enhances digitalis toxicity. 
 
MAGNESIUM : EFFECT ON CARDIAC RHYTHM 
                    Magnesium has modest electrophysiologic effects. Intracellular 
hypokalemia,  hyponatremia and increase of cell excitability may be associated with 
magnesium deficiency. Magnesium has effect on real and adjused SA node conduction 
time, increases  AV  conduction time, has effect on relative refractory periods, during 
ventricular pacing QRS duration is extended  lengths of cycle more than 250 
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milliseconds[46]. Zwillinger[31] was the first person to discover the effect of Mg on 
arrhythmias and was later used widely in the management of arrhythmias and  usefully 
employed  in patients with difficult VTs, VAs induced by digitalis  and in those with 
episodes of  TdP. 
Magnesium was found to be useful in a variety of arrhythmias including both tachy and 
brady arrhythmias and was employed widely in clinical practice for the same purpose. 
Recently many studies have proposed Mg as the most useful drug in various life 
threatening arrhythmias[47]. . 
                      Magnesium is the natural calcium antagonist.Magnesium reduces calcium 
influx to the cells during ischemia and prevents damage associated with ischemia to the 
myocardium. Magnesium also affects systemic and pulmonary vascular impedence and 
causes decrease in many hemodynamic parameters. 
                                         
 Impact of Magnesium on Lipid Metabolism 
Magnesium has an unproven role in the metabolism of lipids.Magnesium therapy showed 
improvement in the cholesterol metabolism such as improvement in the ratio of HDL-C 
and LDL-C plus VLDL- C.The levels of platelet magnesium levels intracellulary has a 
great impact on the role of  platelets in causing thrombosis or atherogenesis. In a study 
non rabbits these organisms were fed on a special diet with high amount of cholesterol 
and different amounts of magnesium and was found that there was a dose dependant 
decrease in aortic lesions and cholesterol content of lesions[48]. A study on rats fed with 
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similar diet but showed adverse effects .  In another study on rats the amount of 
cholesterol content ,LDL and TGs associated with a reduction in the levels of good 
cholesterol.[49]. 
                         Rassmussen et  al [51] found that when diets containing Magnesium 15 
mmol/day showed a significant reduction in the plasma levels of TGLs and VLDL-C and 
a significant reduction in plasma levels of good cholesterol. 
                         Mg was found to be very important part of many of the biomolecules 
involved  in cholesterol metabolism 
                         Another study showed that amont of Mg in thrombocytes  significantly 
related inversely to the levels of total cholesterol. As a result, the low levels of platelet 
cellular magnesium levels can be considered as apossible marker of alterations of the 
membrane of platelets and its involvement in thrombosis and atherosclerosis[52]. 
 
Anticoagulant/ Antiplatelet Properties of Magnesium 
                Many studies have shown that addition of Mg to the fresh notclotted plasma 
had caused an increase in the clotting time. During the world wars , in germany  it was 
found that when magnesium was used as a muscle relaxant in wounded patients it was 
observed that after death during postmortem their blood  didnot clot [53].It was later 
proved that magnesium inhibits human blood clotting[54]. 
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                    Many studies have proven the importance of magnesium in vascular 
complications like myocardial infarctions and cerebrovascular events. Mg prevents the 
growth of thrombus and thus facilitates the opening of the involved coronaries and 
improves the mortality benefit of patients in various studies[55,56]. Magnesium was 
found to be most important cation involved in thrombus formation after calcium. 
                       Very high concentration of magnesium has effects on regulating various 
factors involved in the coagulation cascade. Mg has important roles in the pathogenesis 
of atherothrombosis in MI and has a proven role in the prevention of arrhythmias 
associated with myocardial infarction.  Mg has effects like inactivation of various factors 
involved in the aggregation and activation of platelets and thus prevents thrombus 
formation[57,58]. Even administration of magnesium to control subjects who donot have 
the low serum magnesium level  was found to be beneficial to this regard.  So the crucial 
role of magnesium, in the pathogenesis and prevention of coronary thrombosis and the 
associated arrhythmias is undisputable. This also underlines the correction of low 
magnesium levels in patients with vascular complications and the improvement of 
prognosis associated with these conditions. 
 
 
 
 
13 
ROLE OF MAGNESIUM ON ENDOTHELIAL FUNCTION: 
                        Many studies have shown a crucial role for magnesium on endothelial 
function. Decreased serum Mg has been found to impair NO synthesis. The decreased 
production of  Endothelial nitric oxide leads to decreased vasodilatation and this 
predisposes to vascular thrombosis and endocardial ischemia. The impairment of 
endothelial function associated with magnesium deficiency is proposed  to be  be the 
reason for increased predisposition for myocardial ischemia in patients with 
hypomagnesemia.So the correction of low serum magnesium levels in these patients is 
postulated to improve the prognosis of these patients and decrease the mortality. 
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                                  CORONARY CIRCULATION 
ANATOMY OF CORONARY ARTERIES 
          Blood supply of heart is derived from right and left coronary arteries which arise 
from anterior aortic and left posterior aortic sinus respectively. 
          Right coronary artery after arising from the anterior sinus passes between the right 
auricular appendage and infundibulum of right ventricle. Passing now vertically 
downwards  in the atrioventricular groove the artery turns backwards  at the inferior 
border of  the heart and runs  posteriorly. It  gives  off   branches  to  both   atria  and  
ventricles  as   it  passes  vertically downwards.   At  the  inferior  border,  the marginal  
branch  passes  to the  left along   the   right  ventricle.      On   the   diaphragmatic  
surface,   the   inferior interventricular  branch   is  given  off.     This  large  artery   
passes  along  the interventricular   groove   to   the   apex   of  the   heart.      The   
terminal   part anastomoses with  the  terminal arterioles  of the  coronary  artery at  the 
lower part of the left atrium. 
           The  left   coronary  artery  immediately   after  its  origin   divides  into anterior 
descending artery and left  circumflex artery.  The anterior descending artery runs  in the  
interventricular groove  to anastomose  at the apex  with the terminal branches  of the  
inferior interventricular  artery.   The left  circumflex gives  off branches  to the  posterior  
wall of  the  left ventricle  and runs  on  to anastomose  with  the   termination  of  the  
right   coronary  artery,  below  the coronary sinus.    
15 
  
                           The blood supply to heart is through coronary arteries. Right coronary 
artery (RCA) is originated from the great vessel Aorta, from its anterior sinus. The first 
part of  RCA moves in between the main pulmonary artery and the right atrium.  The 
second part of the RCA runs over the sternal  part of the heart moving between the RV 
and RA. The third part is formed at the lower part of heart moves in the AV groove. 
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CORONARY CIRCULATION Figure A 
  
Left coronary artery (LCA) is from the sinus of the great vessel aorta which is the 
posterior sinus .It moves between the Main pulmonary artery and the left atrial chamber 
of heart. Then the LCA moves into the Sternal surface of heart and forms two channels 
Circumflex artery and another artery anterior interventricular artery. The circumflex 
artery moves in the part of the groove separating atrium and ventricle in its anterior part. 
 
 
 
 
CORONARY CIRCULATION 
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Figure B 
 ANASTOMOSES OF CORONARY ARTERIES 
                    Anastomoses exists between the terminations of right and left  coronary 
arteries  in  the  atrrioventricular  groove  and   these  surface  anastomoes  are 
insignificant.   There  are intercoronary  anastomoses freely  at arteriolar  level, between 
the  inter-ventricular arteries.   If  the intraventricular  arteries meet  at the  apex, this  
provides  maximum anastomoes.    If  the meeting  place  of the intraventricular arteries 
falls short  of the apex above or below, this  diminishes the potential  anastomotic area.  
In  10% of the  individuals the inferior  as well as the anterior  interventricular artery is a  
branch of the  left coronary, in these cases there is no anastomoses between the 
coronaries. 
                   Potential   anastomoses   exists   between   the   coronary   arteries   and 
pericardial arteries which are derived from the pericardiophrenic, the bronchial and the 
internal thoracic arteries.  In very rare instances one of these  may open to replace a 
coronary artery. 
DISTIBUTION OF CORONARIES 
                    Right ventricle  is  supplied by  the right  coronary artery  except  at the 
upper  margin  of  its  anterior  surface,  where  it  is  supplied  by  branches  of anterior 
interventricular arteries. Left  ventricle  is  supplied  by  the  left   coronary  artery  except  
for  a narrow strip  of the diaphragmatic  surface where it  is supplied  by the inferior 
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interventricular artery.    The two  interventricular arteries  share the  supply  of the 
interventricular septum, usually about equally. 
                  The anterior  surface of  the right  atrium is  supplied by  right coronary artery.  
The posterior surface and the auricular appendage of the left atrium are supplied from left 
coronary artery. 
SA Node: It  is supplied by  a branch of  right coronary artery in  60% of cases and from 
left coronary artery in 40%.  AV node and bundle of His are supplied by the  inferior 
interventricular  artery, which arises  in 90%  of cases from  the right coronary and in 
only 10% from the left coronary. 
Dominant Arteries:  In 67% of the  cases right coronary  is dominant, 15%  of cases left  
coronary and  in 18% of  cases there  is a balanced  coronary arterial pattern. 
PHYSIOLOGY OF CORONARY CIRCULATION 
                  Functionally, the right and left coronary arteries behave as end  arteries, 
although anatomically there are numerous intercoronary anastomoses in most of the 
normal hearts in the order of 40% microns in diameter. Only   the  inner   75-100   
microns   of  the   endocardium   can  obtain significant amount of nutrition directly from 
the blood in the cardiac chamber. 
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The Heart is the main pumping organ of the body .It has to give its pumped blood to 
whole body to enable adequate oxygen supply to the body. This occurs through an 
arterial tree, and the main vessel in that arterial tree is Aorta. This vessel arises from left 
part of the ventricles of heart and carries blood rich in oxygen. 
 
 
 
 
HEART AND VESSELS 
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Figure C 
  
The ascending aorta arises from the left part of the ventricle of heart at the level of 3
rd
 
intercostals space of the chest.The part of the mediastinum which contains heart and 
vessels of the heart is the middle mediastinum.The wall of the great vessel aorta has 3 
dilatations which are called as aortic sinuses. 
 
 
 
HEART AND VESSELS 
21 
Figure D 
NORMAL CORONARY FLOW 
                  Resting coronary blood  flow in human  beings averages about  225 ml/ min 
or 0.7-0.8 ml/G of heart  muscle or 4.5 percent of the total cardiac  output. Four to five 
fold increase can occur during exercise. 
PHASIC CHANGES IN CORONARY BLOOD FLOW 
              As a result of cardiac muscle compression blood  flow decreases duringsystole 
and  increases during diastole,  in which  left ventricle is  more affected than the right 
because of its thickness. 
              The  intramyocardial   pressures  compress   the  subendocardial   blood vessels  
more than  the  outer  vessels, which  throttle  its  blood supply  and  to compensate for  
this one,  the subendocardial  vessel  are much  larger than  the nutrient arteries in the 
middle and outer layers of the heart, which increases the blood flow during diastole 
proportionately. 
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                                           MAGNESIUM DEFICIENCY 
 
                      Magnesium deficiency is becoming more commonly recognized  due to 
increased  clinical  awareness,   and  the  greater  frequency  of   assessment  of 
magnesium  status   by  a   physician. The  incidence of magnesium deficiency in 
hospitals , which are tertiary centres is usually 10% , but it rises to 60% in intensive 
coronary care units. The main symptomatic causes of hypomagnesemia is most 
commonly due to GI loss or renal loss of magnesium The main etiologies of magnesium 
loss are: 
DRUGS 
-Diuretics 
-Frusemide, ethacrymic acid) 
-Aminoglycosides 
-Cisplastin 
-Cyclosporin 
-Amphotericin-B 
• Metabolic acidosis 
-Starvation 
23 
-Ketoacidosis 
G I  disorders 
•    Continued NG suction 
•    Poor GI Absorption 
•    Severe Bowel resection 
•    Loose stools, Acute or chronic 
•    PEM 
•    Catastrophic  pancreatitis 
•    Decreased serum magnesium in Neonates 
Magnesium loss via Kidneys 
•    Continued iv fluid therapy. 
•    Loss due to osmotic factors 
•    Increased serum calcium 
•    Other Diseases of kidney like. 
              Chronic pyelonephritis , interstitial nephritis and glomerulonephritis 
             Diuresis period of  ATN 
24 
            Renal tubular acidosis 
            Post renal transplantation. 
       Hypomagnesemia may be encountered in about 28% of patients with acute 
hemorrhagic  or  edematous  pancreatitis.    The  low  serum magnesium concentration 
may be due disorder predisposing to the pancreatitis. 
RENAL MAGNESIUM WASTING 
                    Magnesium loss can occur through many route, but the most  main route is 
kidney route for magnesium loss.The renal absorption of the magnesium, the main site is 
proximal tubule of the nephron and is dependant on Na reabsorption[63].So, continous 
therapy with sodium containing iv fluids will lead to mg loss. Hypercalcemia  is  shown  
to  decrease   magnesium  absorption  in  the proximal  tubule  and loop  of  henle  and  is 
perhaps  the  mechanism  of  renal magnesium   wasting  or   the   tendency  towards   
hypomagnesemia   in  most hypercalcemia states[64]. 
Gastrointestinal Disorder 
The  content of magnesium in the stools and biliary fluid is greater compared to other 
fluids, so hypomagnesemia is common in patients with chrons disease and intestinal 
inflammation. Vomiting and loose stools form an important component as magnesium 
because of the high Mg content of GI tract. The damage to the intestinal mucosal layer 
cells due to the therapeutic interventions for many malabsorption states like whipples 
disease can lead to low serum magnesium levels.  Another cause of low serum 
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magnesium levels is because of poor gastrointestinal absorption of lipids leading to poor 
magnesium absorption.  Various surgical interventions for obesity and poor GI absorption 
like Intestinal resection can also result in low serum magnesium[65]. 
            The  commonest  cause  of  magnesium  wasting  is  concurrent  use  of diuretics.   
Diuretics  acting   on  the  proximal   tubules,  such   as  carbonic anhydrase inhibitors 
and osmotic agents, may  increase moderately magnesium excretion. Diuretics  acting  at   
the  loop  of  henle   such  as  frusemide  and ethacrynic acid result in magnesium 
deficiency. Aminoglycoside  therapy initially  with  capreomycin,  gentamycin and 
recently with  tobramycin,  amikacin has  produced renal  magnesium wasting. Another 
cause of magnesium loss and hypomagnesemia is Therapy with Amphotericin B. Another 
chemotherapeutic drug Cisplatin alo causes loss of Mg through kidney route in many 
patients treated with patients. 
Endocrine and Metabolic Disorders 
                  Many diseases associated with various systems in body are associated with 
low magnesium levels. Of these an important diseases involve the hormonal system 
which controls the metabolic functions of the body. Many Of the diseases like Type 2 and 
type 1 diabetes mellitus is associated with low serum levels of magnesium[68].  The 
mechanisms responsible may be varied. These include the effect of the hormone insulin 
on the distribution of Mg in bodyfluids. It drives Mg inside the cells. Also loss of 
magnesium may occur through the kidney route and this accounts to the role of osmotic 
factors[69]. Hypomagnesemia can  be found in  association with a  number of other 
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endocrine  abnormalities.   Phosphate  depletion  has  been  shown  to result  in  urinary 
magnesium wasting and hypomagnesemia.   That is hypophosphatemia is a contributing 
factor in the development of magnesium deficiency. Other    conditions   leading    to    
urinary   magnesium    wasting    and hypomagnesemia is  thyrotoxicosis.   The cause of 
Mg deficiency associated with disorders involving Renin Angiotensin aldosterone system 
may be related to the increase in the human body fluid status and the consequent 
excretion of mg through the kidney route. 
Miscellaneous Causes 
                 Mg depletion may occur because of unusual routes of excretion of Magnesium 
such as increased sweating and other rare routes of excretion. 
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  EPIDEMILOGY OF CORONARY HEART DISEASE 
                    Coronary  Artery Disease  (CAD)  is  a  major cause  of  morbidity  and 
mortality in individual  aged 45 years  or more throughout the  world including India.   
Wide variations  have been reported  in the  prevalence rate of  CAD in different  
geographical regions.    Finland  and  US lead  all  other  countries in death rates from 
CAD.  
                    In the  US it  is estimated  that for  those over  30 years  of age  213 per 
100,000 individual have ischaemic heart disease. Accurate  data  regarding   the  
prevalence  of   CAD  in  India  are   not available.    Surveys   carried  out  in  recent  
years,   in  different  geographical locations and  in small population groups  using 
different protocols,  estimate a prevalence rate of about 5% in  urban population and a 
much lower prevalence in the rural setting.  
The pattern of CAD in India has been reported to be as follows: 
a)   Males are affected more than females. 
b)   Hypertension and diabetes accounts 40% of all cases. 
c)   Heavy smoking is responsible etiology in a good number of cases. 
d)   Other factor  includes  high  fat &  energy  rich  diet, sedentary  life style. 
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The lesion which occurs at the onset of atherosclerosis is Fatty streak which is formed by 
the accumulation of fatty compounds on the vessel wall in the intimal layer of blood 
vessel.Then the migration of wbcs to the wall of the heart vessels occurs and these cells 
get loaded with lipid and forms the so called foam cells. 
 
28 PATHOGENESIS OF ATHEROSCLEROSIS 
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Figure E 
  PATHOPHYSIOLOGY OF ACUTE MYOCARDIAL INFARCTION 
                     Myocardial   infarction  generally   occurs   when   there  is   an   abrupt  
decrease  in   coronary  blood  flow   following  a  thrombotic   occlusion  of   a coronary   
artery  previously   narrowed   by   atherosclerotic   plaque  fissures, ruptures or  ulcerates 
and  when conditions  favor thrombogenesis  takes place, so that  a  mural thrombus  
forms at  the site  of  rupture and  leads to  coronary artery occlusion.   After  an initial  
platelet monolayer  forms at  the site  of the ruptured plaque, a  variety of agonists 
(collagen, ADP,  epinephrine, serotonin) promote platelet activation.  Following agonist 
stimulation, there is  production and  release   of  thromboxane   A2 ,  further   platelet  
activation   and  potential  resistance to thrombolysis. 
                  In addition to  generation of thromboxane A2 ,  activation of platelets by 
agonists  promotes   a  conformational  change   in  the   glycoprotein  IIb,  IIIa receptors.  
Once converted  to its functional state this  receptor develops a high affinity for  the 
sequence  arginine – glycine  – aspartic  acid on the  fibrinogen alpha chain  and also  for 
a dodecapeptide  sequence on  the fibrinogen gamma chain.  Since fibrinogen  is a 
multivalent molecule, it can  bind to two different platelets simultaneously, resulting in 
platelet cross linking and aggregation. 
 
                          Ultimately  the  amount   of  myocardial  damage  caused  by   coronary 
occlusion depends on  the territory supplied by  the affected vessel, whether  or 
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not the vessel  becomes totally occluded,  native factors that can  produce early 
spontaneous lysis of the occlusive thrombus, the  quantity of blood supplied by 
collateral  vessels to  the  affected  tissue,  and the  demand  for  oxygen of  the 
myocardium whose blood supply has been suddenly limited.Depending on the extent of 
coronary occlusion, ischemia can be limited to the subendocardium or can involve the 
entire thickness of the myocardium, ie, a transmural infarction.Transmural infarction 
typically results in ST elevation myocardial infarction where as subendocardial ischemia 
leads to ST depression in ECG and is termed as Non- ST elevatin myocardial infarction. 
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      CLINICAL FEATURES OF ACUTE MYOCARDIAL INFARCTION 
                   Acute  myocardial  infarction presents  itself  as  a  sudden catastrophic 
incident and  its definite  clinical picture may  be established  without warning. 
The clinical pictures can be classified as follows: 
1)   Cases dominated by chest pain 
2)   Cases dominated by shock 
3)   Cases dominated by pulmonary edema or other evidence of LV failure. 
4)   Cases characterized by the gradual development of CCF 
5)   Cases dominated by complication 
6)   Some cases may present with combination of any of the above. 
1. CHEST PAIN 
                    In 80-85% of cases this  is a presenting complaint.  It is  a deep visceral pain, 
involving  the central portion  of the  chest and epigastrium,  described as tightness, 
heaviness or constriction in the chest.   In 25% of cases, it radiates to the  arms  and  
commonly  it   is  often  accompanied  by  weakness,  sweating, nausea, giddiness  and 
anxiety.   It  may occurs during  exertion and  emotional outbursts, not  relieved  with rest  
and makes  the patient  to  move about  in an attempt to find a comfortable position. 
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The pathophysiology of myocardial infarction involves thrombosis nof the lumen of the 
blood vessels leading to ischemia of myocardium leading to myocardial infarction. This 
can be ST elevation or NSTEMI. ST elevation myocardial infarction has a pathogenesis 
of total block of coronaries leading to full thickness destruction of myocardium. 
 
PATHOPHYSIOLOGY OF ISCHEMIC ST ELEVATION 
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Figure F 
2.   Breathlessness 
                       Second  most  important  symptom,  breathlessness  may  be  sudden  in 
onset  and intense  or it  may  be exertional.    It is  common in  those  who had painless  
myocardial  infarction’ particularly  diabetics  and  aged  individuals, and those having 
complications like cardiogenic shock and pulmonary edema. 
3.   Sudden  loss  of consciousness,  a  confusional  state,  a sense  of  profound weakness  
or unexplained  fall  in blood  pressure  with giddiness,  syncope and/ or convulsions may 
be a presenting complaint. 
4.   Choking sensation in the neck may be the only presenting symptom. 
5.   Some  patients present  with  gradual  onset of  breathlessness,  paroxysmal nocturnal  
dyspnea  and  pain  in  abdomen  with  oliguria  and  swelling  of lower limbs, a picture 
that of CCF. 
6.   In rare cases the infarct may go  unrecognized until endocardial thrombosis resulting 
from its leads to systemic embolism. 
Physical  Signs.     Patient  may  come   with  the  hand  on   their  pericardium indicating 
the site of maximum intensity of pain (Levine sign). often associated  with perspiration 
and  coolness of extremities,  cyanosis may be there when the patient is having severe 
pulmonary edema or shock. 
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Pulse 
                     May  show  bradycardia,   normal  sinus  thythm,  tachycardia   with  or 
without irregularities, depending  upon the presence or absence  of arrhythmias and the 
type of arrhythmia. 
Blood Pressure 
                   Usually   shows   an   initial   rise   because  of   pain,   anxiety   or   the 
unfamiliarity  of the  environment,  which  will become  normal  within 3  or  4 days.   
Fall in  the blood  pressure may be  due to  cardiogenic shock  or due  to ‘Bezold-Jarisch  
reflex’, which  is  due to  increased  vagal tone  that occurs  in inferior wall infarction. 
Neck veins: 
                 Collapse of neck veins occurs  when patient is in shock, cannon waves can be 
made out in complete heart block in which they are irregular. 
Precordium 
               The apical impulse  may be difficult to  palpate.  In about one-fourth  of the  
patients  with  anterior   wall  infarction,  an  abnormal  systolic  pulsation, develops in 
the  periapical area within the first  few days of illness,  which may resolve  later,  which 
represents  a  transient,  palpable  systolic bulging  of  the infarcted ventricle.   Other  
physical signs of  ventricular dysfunction  that may be present  are,  muffled heart  
sounds, atrial  (S4)  and ventricular  (S3) gallop sounds and  paradoxical splitting of  the 
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2nd  sound.   A transient apical  systolic murmur due to mitral  regurgitation secondary to 
papillary muscle  dysfunction during  acute infarction  may  occur.    A pericardial  
friction  rub  is  audible if infarction is transmural in most of the cases. Temperature 
elevations in  the range of 37 to  38ºC are common during  the first 3 to 4 days due to 
myocardial necrosis. 
Respiratory System: Tachypnea  is common and crepitations  are heard at the base  or  
all over  the  lung  fields  depending upon  the  amount  of  pulmonary congestion. 
Gastrointestinal System: enlarged tender liver will be present  when patient is in CCF. 
Central   Nervous    System:   Anxiety,   restlessness,    stupor,   coma,    focal 
neurological  deficit  may   occur  when  the   patient  is  having  fall   in  blood pressure 
and/ or thromboembolic phenomenon. 
Renal System:  Oliguria may  be present if  the patient  is having fall  in blood pressure. 
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                MAGNESIUM AND ACUTE MYOCARDIAL INFARCTION 
 
                       Epidemiological   studies    have   suggested    that   the    incidence   of 
myocardial  infarction and  of  sudden  death  is higher  in  areas  of  soft water  intake .   
Cardiac  magnesium content has  been reported  to be low  in patients whose  death   was   
attributed  to   myocardial  infarction[16].   It  is   unknown however, if  the low  cardiac 
content  proceeds the  myocardial infarction  or is result  of   it.     Cardiac   magnesium  
exchanges   quite   rapidly  with   plasma magnesium and   a number  of clinical  studies 
have shown  a fall in  the serum magnesium  concentration  within  the  first  24  to 48  
hours  after  myocardial infarction.     Infarcted  myocardium   has  been   repeatedly  
shown  to   have reduced  magnesium content.    But  the  results regarding  the  study  of 
serum magnesium values in first  24 hours, following acute myocardial infarction has 
been variable.  Some found no significant change of serum magnesium.  It has, therefore  
been proposed  that  serum  magnesium  has an  inverse  relationship with  coagulability  
of  blood  and  serum  cholesterol  levels,  following   acute myocardial infarction. 
                      Myocardial  injury   was  established  by   histological  examination   of 
cardiac  tissue.     A   significant  rise   in  urinary   magnesium   excretion  was observed 
during the first two  hours after which the level declined but  was still maintained   above    
the   control  level  significantly in infarcted myocardium. Magnesium   content    
decreased significantly in infarcted myocardium. 
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Management of Patients with Acute myocardial infarction is dependant on various 
factors. Of these the most important factor is Time. ST elevation Myocardial infarction 
can be treated with two options.One is percutaneous coronary intervention and the other 
option  is Thrombolysis using fibrinolytics. 
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MANAGEMENT OF STEMI 
FIGURE G 
Figure G 
 Various   authors  have   reported   a   decrease  of   serum   magnesium following   MI.     
Abraham   S  et   al[17]   (1980)  from   Israel   checked  serum magnesium levels of  
forty two patients of acute  MI, nine patients of  coronary insufficiency and  fourteen  
patients of  non-cardiac chest  pain.   Patients  with acute myocardial  infarction  and 
those  with acute  coronary insufficiency  had lower serum  magnesium levels  than 
eighty  controls  natural for  age and  sex, whereas  there  was  no  difference   in  patients  
with  non-cardiac  chest  pain. There was a significant fall of  serum magnesium during 
the first five days andth normal levels were reached by the 12   day. 
                      Singh  A  et al[60]  (1976)  checked  serum  magnesium  levels of  twenty 
patients of acute MI on the first 7   and  12   day of admission.  In all the cases, there was 
a significant fall of serum magnesium on the first day. 
                      Babel  S.Bhatnagar, HNS  Bhatnagar[18] (1983)  from Rajasthan  tried  to 
determine the prognostic significance of serum  magnesium levels in acute MI. Twenty  
five  patients  of  acute  myocardial  infarction  were  studied.   Serum magnesium  was  
found  to  be  significantly  lowered  on  the  first  day  and  it gradually rose to normal 
value by the twenty first day. 
                      But some  studies  have showed  that magnesium  depletion  resulted in 
lowered   intracellular   magnesium   and   potassium,   increased   intracellular calcium  
and  sodium,  and  focal  cardiac necrosis[19] . Patients  with  coronary artery  disease 
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have  been  found  to  have decreased  amount  of  exchangeable magnesium and patients 
sustaining  an acute myocardial infarction  were found to retain abnormally high amounts  
of magnesium during magnesium tolerance testing and  to have  lower skeletal  muscle 
magnesium  content suggesting the presence of magnesium deficiency[20].Magnesium   
depletion   predisposes   to   vascular   spasms,   including coronary  artery  spasm  and   
potentiates  the  contractile  response  to  pressor agents  such  as  angiotensin   II  and  
norepinephrine.    Magnesium   depletion potentially could  worsen  angina and  
precipitate acute  myocardial  infarction. The  effectiveness  of magnesium  therapy  in  
acute  MI has  been  reported  to decrease  infarction  size, decrease  the  incidence  of  
cardiac arrhythmias  and lower mortality rate[21,22,23}. 
Mechanism of Tachydyrarrhythmias: 
                     The  exact  mechanism  behind   the  effect  of  magnesium  on  cardiac 
dysarrhythmias is  unknown.   Magnesium  is essential  for activation  of  ATP, which  
maintains  the  sodium-potassium  pump.    Therefore,  it  may  have  an important role in 
maintaining the  resting membrane potential of electrocardiac cells,  which  depend  on   
the  intracellular  potassium  gradient.    Magnesium deficiency  is associated  with  loss  
of intracellular  potassium,  an  increase in intracellular  sodium,  and  an   increase  in  
cell  excitability.    One  theory   of magnesium  and  dysarrhythmias suggest  failure  of  
potassium  to  reenter the depolarized cell or a diastolic leak of potassium from already  
depolarized cells may   promote    aberrant   condition,    reentry   phenomena    and   
ventricular fibrillation[26,27]. 
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                   Another  theory is  that  magnesium acts  as a  calcium  blocking agent. The 
increased intracellular  sodium linked with magnesium  deficiency may be followed by  a  
sodium-calcium exchange  causing an  increase in  intracellular calcium. Phasic  influx   
of  intracellular   calcium  is  linked   with  transient depolarization and  repetitive 
dysarrhythmias,  infusion of  magnesium cause a clinical  picture similar  to  that  
produced  by infusion  of  a  calcium  blocking agent, peripheral  vasodilatation, flushing,  
a decrease  in blood pressure  and a decrease in contractile strength of the heart[28]. 
                       Lysophosphatidyl choline  (LPC) is an endogenous  lipid released from cell 
membranes during ischemia and  has potent local effects on cardiac tissue. LPC causes 
membrane depolarization by decreasing potassium conductance of the  inward  rectified   
current  and  induces  cardiac   arrhythmias.    LPC  also triggers the  accumulation of  
intracellular calcium  in heart  cells by inhibiting the sodium-potassium  adenosine 
triphosphatase (ATPase)  pump[29]   .  Increased systolic calcium  can be  detrimental to  
cells by  activating calcium  dependent phospholipases and  proteases  and by  generating 
additional  toxic  fatty acids. 
                      Excess  free intracellular  calcium  also potentates  the  harmful effects  of  
free radicals [30]  .  Because magnesium is a critical cofacors  of myocardial ion pumps 
and antagonizes calcium influx.    Antiarrhythmic effects of magnesium during ischemia  
were   mediated  by  inhibition   of  increasing  intracellular  calcium induced by LPC. 
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Ventricular Tachydysarrhythmias  and magnesium 
                   In 1935,  Zwillinger  [31]  injected 15 ml  of a 20%  solution of magnesium 
sulfate  (MgSO4 )  as  a  bolus  into  left ventricle  of  a  patient  with  ventricular 
fibrillation   resistant    to    other   therapy. In 1943, Boyd  and Schesf  [32]  used 10-20 
ml  of IU 10% MgSO   to treat spontaneous dysarrhythmias with an approximately 50% 
success rate. Rasmussen et  al[33]  , experimental  patients received approximately  1200 
mg  of  magnesium  chloride  (MgCl  )  in  the  first  24  hours  after  AMI  and 
approximately 300  mg in  the second 24  hours.   Results were compared  with  placebo  
control  group.    Those treated  with  MgCl   had  significantly  fewer incidence   of   
dysarrhythmias   requiring   intervention   (21%   versus    47%) (p<0.05). Ventricular 
dysarrhythmias induced  by digitalis toxicity  are extremely responsive to magnesium 
therapy.    Hypomagnesemia is common during digitalis toxicity and even  in the 
presence of normal  serum magnesium, intracellular   magnesium  is   frequently  low.  
Magnesium   counteracts   the inhibitory  effects of  digitalis  on  sodium/  potassium 
ATP.  During  digitalis therapy, there  is an  increase in intracellular  calcium leading  to 
augmentation of  ionotropism and  excitability [34]  .   In  a  study  in  monkeys, low  
magnesium levels were associated with a decrease in tolerance to digitalis and the 
duration of digitalis toxicity was prolonged. 
                      Holden   et   al[35]   found   a   striking   decrease   in  Mg2+   both   during 
cardiovascular  bypass  surgery  and  1-day  postoperatively.    Dysarrhythmias after   
cardiovascular    surgery   are   believed    to   be   partially    caused   by 
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hypomagnesemia resulting  from the use of  anticoagulants during surgery  i.e., 
anticoagulants bind  Mg   .   The use  of Mg++  in the  postoperative  period has 
decreased the incidence of dysarrhythmias. 
Torsades de Pointes 
                        Torsades    de    Pointes    (TdP)    is    a    life-threatening     ventricular 
dysrhythmia.   This  repetitive  polymorphic ventricular  tachycardia  occurs in the 
presence of  QT prolongation.   TdP is most commonly  induced by type  Ia 
antidysrhythmic   drugs  such   as   quinidine  or   disopyramide.     Other   QT- 
prolonging  drugs,  such  as  amiodarone,  have  been  reported  to  cause  TdP. 
Hypokalemia  and hypomagnesemia  can  potentiate  the  development of  TdP and in 
rare cases can be the cause[36].In a longitudinal study of 12 patients with TdP treated 
with intravenous MgSO , a  single bolus of 2g of  MgSO  completely abolished  TdP 
within  5  minutes in  nine  patients[27]   .   In  the other  three  patients,  a second  dose  
of MgSO   was given  5 to  15 minutes later  completely corrected  TdP.   No side effects 
were associated  with the treatment.   Similar findings were reported by Perticone et 
al[37]. 
Atrial dysrhythmias 
                      Hypomagnesemia has been shown  to make control of atrial fibrillation 
(AF)  difficult [38] .   In  one  study of  45  consecutive patients  with  symptomatic 
AF,20%  had serum  magnesium levels  <1.5  mEq/L.   In  a blinded  treatment protocol, 
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hypomagnesemic  patients required  twice the  amount of  IV digoxin to control  AF.  
This study  suggests that monitoring  and replacement of  Mg++ may be  beneficial in 
patients  with symptomatic  AF, especially when  digoxin therapy is considered[39].  
 
MANIFESTATIONS OF MAGNESIUM DEFICIENCY SIGNS AND SYMPTOMS 
                       The lack of  Magnesium in diet in normal people leads to characteristic 
symptoms like change of character, spasticity of limbs,coarse tremor and muscle spasms.. 
The main causes of low serum magnesium levels are usually reactive to other major 
causes, so these causes may be masked by the  manifestations of those primary causes.     
Manifestation   associated with  moderate to severe magnesium deficiency is shown in 
Table-1. 
Table-1 
Manifestations of Moderate to Severe Magnesium Deficiency 
Biochemical 
Hypokalemia 
•    Loss of potassium through urine. 
•    Intracellular Mg deficiency. 
Hypocalcemia 
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•    Decreased secretion of parathyroid hormone. 
•   Lack of effect of PTH on kidnys and bones 
•    Lack of response to vit D. 
Neuromuscular 
•    Presence of carpopedal spasm 
•    Spontaneous Trousseau sign positivity. 
•    convulsions 
•    giddiness, aincoordination, visual disturbance, involuntary movements. 
•    skeletal weakness , atrophy and fibrillation 
•    Psychiatric manifestations 
Cardiac Arrhythmias 
ECG – PR and QT prolongations 
AT,PAC,PVC 
VT 
VF 
TdP 
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                          DIAGNOSIS OF MAGNESIUM DEFICIENCY 
                      Serum Magnesium Concentration is affected b the compartmentalization of 
magnesium in various parts of the fluid compartments of the human body.    The serum 
magnesium  concentration may  not reflect  the intracellular  magnesium content.   The  
measurement  of  serum magnesium  concentration  is  the  most commonly  employed  
test  to  assess  magnesium  status.   The  normal  serum magnesium of less than 1.7 
mg/dl usually indicates magnesium deficiency. Exogenous and endogenous  
catecholamines have been shown to  result in   a   slight  fall   in   the   serum   
magnesium   concentration   and  increased catecholamine secretion could  be a 
contributing  cause of hypomagnesemia  in acute illness  and  stress[17]  .   Volume  
contraction and  rhabdomyolysis  (cellular magnesium   release)   can   cause   an    
increase   in   the   serum   magnesium concentration and may mask an intracellular 
magnesium deficit. 
Other methods to estimate the physiologically active Mg has lead to the discovery of 
many new methods . Of these the most important is peripheral lymphocyte magnesium 
concentration which has a good relation to the concentration of physiologically active 
magnesium in various parts of body. 
Magnesium Tolerance Test: This is among the commonest method used for estimating 
low serum magnesium level patients. Many studies have confirmed that the serum levels 
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of magnesium after a bolus dose of Mg is low in patients with low serum magnesium 
level as well as in those at risk for the same 
The procedure is: 
1.   Obtain the initial level of the  Mg – Cr( creatinine) value 
2.  Give 0.2 meq (= 2.4  mg) Mg / kilogram BW  infused in fifty ml of 5% D over a 
period of  few hrs. 
3.   Do a twenty four hour urine collection for Mg levels. 
4.   Obtain the amount of Mg left back in the body    
5.   Hypomagnesemia : the Criteria to diagnose 
More than fifty percent retention = Hypomagnesemia definite diagnosis 
More than twentyfive percent leftback   = Hypomagnesemia probable diagnosis 
Treatment of Magnesium Deficiency 
Patient who lack magnesium or who manifest magnesium deficiency or are at risk for 
deficiency should be treated with magnesium containing diet, and is optimal in most 
patients. But those who lost Mg in loose stools or kindey loss of Mg should be treated 
with external doses of Mg. Kidney function tests should be checked in all patients 
presenting with low serum magnesium,  Kidney is a major route of elimination of 
magnesium, ie more than 50 % is excreted in kidneys. So renal failure is a obstacle  in 
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giving large intravenous doses of magnesium.Severe and symptomatic hypomagnesemia 
should be treated with parenteral therapy of Mg. 
Administration of Parenteral Magnesium 
                  Although a  single dose  of IV  Mg2+    may be  effective, the kidney  will 
excrete a large amount of the dose delivered. The  American Society  of Hospital  
Pharmacists  recommends that  the maximum loading dose of Mg2+ be 150 mg/min   .  In 
emergency situations of ventricular tachycardia or ventricular fibrillation, the  adult 
ACLS regimen is 1g diluted  in 100  mL given over  1 to  2 minutes   .   During this 
treatment,  the electrocardiogram should be monitored continuously  to avoid cardiac 
toxicity. Blood pressure  should be  monitored closely during  IV replacement  of Mg++, 
with the infusion  slowed if the patient becomes  symptomatically hypotensive. Common 
side  effects  of rapid  IV administration  of  Mg++ include  cutaneous flushing, sweating, 
and sensation of heat,  hypotension,  decreased deep tendon reflexes,  somnolence,   
hypocalcemia,  tetany,   respiratory  insufficiency , paralysis, and cardiac arrest can 
occur. These side  effects can be  alleviated by slowing  the infusion.  Patients also  
require  monitoring  of  the  serum  magnesium  level,  neurologic  status, respiratory  
status,  and renal  function.    Patellar  reflexes should  be  assessed before starting  
treatment and  monitored carefully  during treatment.   Therapy should be stopped if the 
reflexes become suppressed. 
                    If the patient has  renal insufficiency, the magnesium dose is  decreased 
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by 25% to 50% to  prevent hypermagnesemia.  Replacement therapy is  closely guided   
by  the   serum  magnesium   level   to  avoid   toxicity.     A   potential complication from 
MgSO4   administration is  hypocalcemia.  The sulfate  binds with  calcium,  forming  
sulfate  and  reducing  ionized  calcium.    Zaloga  and Charnow recommended  IV 
magnesium chloride,  rather than MgSO4   to avoid calcium sulphate precipitation.  
Calcium gluconate  should be kept available as an  emergency  treatment  in  the  event  
of hypocalcemia,  tetany  or  overdose  apnea. 
Administration of Oral Magnesium 
                       For  non-serious  conditions oral forms of  magnesium supplementation are 
available,  although gastrointestinal  absorption may  vary.  Large  doses of oral  
magnesium  salts  often  cause  diarrhea.    However,  Mg++  in   the  Mg++ chloride  salt  
form or  in  enteric-coated  tablets is  usually  well  tolerated.   A course of  three 
magnesium chloride  tablets a day  for 30 days  will reduce the deficit  for most  patients  
. For patients  taking  diuretics, the  substitution  or addition of a potassium/ magnesium-
sparing diuretic is probably beneficial. 
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                                               HYPERMAGNESEMIA 
Hypermagnesemia is usually because of treatment with Mg and can also be due to kdiney 
problem, which can be acute or chronic. The most common cause isn iatrogenic Mg 
supplementation which may be oral or parenteral administration. Mg level increases in 
response to GFR rate decrease but in early kidney disease  serum Mg levels usually 
remain normal.    Magnesium excess can be treated using treatment options  like dialysis, 
but these procedures can result in high serum magnesium because of high concentration 
of magnesium in iv fluids  and dialysate fluid. 
                      Other causes of hypomagnesemia can be complications in pregnancy like 
treatment for eclampsia in pregnancy like magnesium sulphate therapy, addisons disease 
or decrease thyroid hormone levels.    
                      Magnesium containing drugs like laxatives cause hypermagnesemia  in 
patients with normal renal function.The central nervous system findings in patients  with 
hypermagnesemia include loss of DTR. In patients with more profound increase of serum 
magnesium itn can lead to paralysis of skeletal muscles and lead to weakness of all 4 
limbs, neck muscle weakness ,paraparesis  ,apnoea or respiratory failure.But mentation 
may remain normal in patients at this stage of increased serum magnesium, but severe 
deficiency will lead to stupor and coma and even death.ECG changes of hypo 
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magnesemia include prolongation of PR interval,ventricular arrhythmias,supraventricular 
arrhythmias,intraventricular conduction problems.At very severe hypermagnesemia may 
lead to death from cardiac arrest. Magnesium can be used as a tocolytic and can be used 
in the treatment of preeclampsia and seizures associated with pregnancy and the basis for 
this action is direct depressant effect on neuromuscular junction,smooth muscles. Migrain 
treatment also employs Mg  and this treatment is becoming popular. High dose of 
magnesium present in therapeutic doses of magnesium containing drugs  can lead to 
hypermagnesemia in patients with abnormal renal function.Symptomatic cases can be 
treated with dialysis to remove the excess magnesium. 
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MATERIALS AND METHODS 
                                              MATERIALS AND METHODS 
DATA SOURCE 
                     60 Cases of Acute Myocardial Infarction , admitted to Intensive Coronary 
Care Unit of  Thanjavur  Medical  College  Hospital over  11 months  ie., between  July  
2014  to  May 2015. 
INCLUSION CRITERIA FOR PATIENTS 
              Patients were diagnosed to have Acute Myocardial Infarction , only if they had 2 
of the following characteristics: 
                    1)  Chest Discomfort. 
                    2)  ECG features of Acute Myocardial Infarction. 
                    3)  Elevation of  Cardiac  Enzymes. 
Only those patients presenting to the hospital within 12 hours of the onset of symptoms 
were included in the study. 
EXCLUSION CRITERIA FOR PATIENTS 
                 Patients  with  hypokalemia. 
Selected patients were subjected to detailed history and thorough  physical examination 
and routine investigations like hemoglobin, Total leucocyte count, Urine examination, 
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blood sugar, Blood urea, Serum creatinine, serum electrolytes , fasting lipid profile, 
cardiac enzymes and Echocardiography was done in all cases. 
Serum Magnesium level was done on Day-1 and Day-5. 
METHOD OF SERUM MAGNESIUM ESTIMATION: 
Method: Calorimetric end point test. 
Reagent : Xylidyl blue reagent. 
Magnesium Standard: 2.5 mg/dl. 
Principle: 
               At alkaline PH , Magnesium reacts with Xylidyl blue and produces a chelating 
red compound.The increase in red colour  or  decrease in blue colour  is proportional to 
magnesium concentration. 
SPECIMEN  
               Non hemolysed sserum or Lithium Heparin plasma may be analysed since the 
magnesium concentration inside erythrocytes is 10 times greater than that in ECF, 
Hemolysis should be avoided and serum should be separated  from the cell as soon as 
possible. 
REFERENCE RANGE FOR MAGNESIUM 
Serum Magnesium : 1.6 -2.4 mg/dl 
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RESULTS 
                                                          RESULTS          
                          
 
 
 
 
 
                          TABLE 1 : Age and sex distribution of the study group 
 
Figure 1 : Age and Sex distribution of study group 
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MALE 
FEMALE 
Age Range(yrs) Male Female TOTAL 
30-40 8 1 9 
40 – 50 9 5 14 
50 – 60 10 5 15 
60 – 70 14 4 18 
70 - 80 4  - 4 
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                     In this study of 60 cases , 48 were males and 12 were females with male 
female ratio of 4:1. The maximum incidence of acute myocardial infarction was seen 
between  6th  and  7 th decades of life followed by fifth and sixth decades. 30 % of 
patients were in the 6 th to 7 th decades and 25 % of patients were in the fifth and sixth 
decades. 
 
TABLE 2: Religion wise distribution of cases 
RELIGION NO. OF CASES PERCENTAGE 
HINDUS 48 80 % 
MUSLIMS 12 20% 
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   FIGURE 2: RELIGION WISE DISTRIBUTION OF CASES 
  
RELIGION 
HINDUS80% 
MUS 20% 
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DIET 
In this study of  60  patients, 25 percentage (15 patients)  were vegetarian by diet and  75 
percentage (  45 patients ) of patients consumed mixed diet. Non – vegetarians have 
higher risk for acute myocardial infarction owing to the higher cholesterol content in the 
diet. 
 
 
 
 
DIET 
NON- VEG 
VEG 
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Figure 3 
  
                TABLE 3 : RISK FACTORS 
RISK FACTORS NO. OF CASES PERCENTAGE 
SMOKING 45 75% 
FAMILY HISTORY OF 
HTN,IHD,DM,CVA 
15 25% 
OBESITY 12 20% 
HYPERTENSION 30 50% 
DIABETES MELLITUS 21 35% 
DYSLIPIDEMIA 15 25% 
 
SMOKING 
                    In  the study,  smoking  is  the most  common  risk  factor found  in  the 
patients  with  acute   myocardial  infarction.    Cigarette   smoking  accelerates coronary 
atherosclerosis in both  sexes and at all ages and  increases the risk of thrombosis,  plaque  
instability  and  myocardial   infarction.    In  addition,  by increasing   myocardial   
oxygen    needs   and   reducing   oxygen   supply,    it aggravates angina. 
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HYPERTENSION 
                    In the present study, out of  60 patients, 30 patients were found to be 
hypertensive based on history  and blood pressure measure ment. In this study 
Hypertension was found to be the second main risk factor (50%) for the development of 
acute myocardial infarction. 
In the present study ,out of  60 patients, 21 patients ( 35%) were found to be diabetic and 
15 patients (25%) were found to have dyslipidemia. 
 
                                TABLE-4 : TIME OF PRESENTATION 
TIME AT 
PRESENTATION 
NO. OF CASES PERCENTAGE 
0 – 3 HOURS 15 25% 
3  -  6 HOURS 30 50% 
 
In the present study , 30 cases ( 50% of cases) presented to hospital between  3-6 hours of 
onset of chest pain and 15 cases (25%) cases presented between 0 – 3 hours. 
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PRESENTATION TO THE HOSPITAL 
Presentation to the Hospital 
Chest pain was  the commonest symptom and  was present in  all of the patients  in the  
present study  (100%).   In  this study  chest  pain is  associated with   sweating   15   
(25%)   of   patients.     Chest   pain   is   associated   with breathlessness  in 15 (25%) of  
the  patients.   Palpitation associated  with  chest pain was present in 6 patient (10%). 
Variation in type of Myocardial Infarction 
In the present study of  60 patients, 25 (41.66%) patients had anterior  wall 
MI,  20  (33%)  patients  had   inferior  wall   MI  and  15  (25%)  patients   had 
anteroseptal MI 
TIME 
 0-3 hours 
3-6 hours 
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Figure 4 
. 
Serum   magnesium   in   Acute   Myocardial   Infarction   in   Relation   to 
Arrhythmia 
In this cross sectional study of  60 patients, the  mean serum magnesium 
level  on   day-1   in  all   60  patients   was  1.78±0.32   and  the   mean  serum 
magnesium level on day-5 was 2.32±0.44. 
Mean  serum magnesium  level  in  the group  with  Arrhythmia on  Day-1 
and Day-5 
In  the  present  study,  out of  60  patients  30  patients  had  significant 
ventricular    premature   contractions/    ventricular   tachycardia/    ventricular 
fibrillation during their 5-days course in the hospital 
TABLE – 5:   Serum magnesium levels in patients with  Arrythmias 
SERUM 
MAGNESIUM(mg/dl) 
 
Day - 1 
 
PERCENT 
 
DAY - 5 
 
PERCENT 
< 1.6 12 20% 6 10% 
1.6  to 2.50 18 30% 24 40% 
>2.5 - - - - 
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 TABLE 6: Serum magnesium levels in patients without Arrythmias 
Serum 
magnesium 
(mg/dl) 
 
Day 1 
 
PERCENT 
 
DAY 5 
 
PERCENT 
<1.6 6 10% - - 
1.6 – 2.5 18 30% 21 35% 
>2.5 6 10% 9 15% 
 
TABLE 7: MEAN SERUM MAGNESIUM LEVEL 
 DAY 1 DAY 5 
Mean serum Mg in 60 cases 1.78 +_ 0.32 2.32 +_ 0.44 
Mean serum Mg level in 
patients with arrhythmia (30 
patients) 
1.58 +_ 0.30 1.96 +_0.32 
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 FIGURE -5 : MEAN SERUM MAGNESIUM LEVEL 
 No of cases Serum 
magnesium 
(Day 1) 
 
p -value 
Mean serum 
Mg in patients 
with arrythmia 
 
30 
 
1.58 +_ 0.30 
 
 
 
<0.001 
Mean serum mg 
level in patients 
without 
arrythmia 
 
30 
 
2.10 +_0.50 
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 TABLE: 8: Comparison of serum magnesium level in patients with Arrythmias and 
without Arrythmias (Day – 1) 
The  above   table  shows   that  out   of  60  patients,   30  patients   had arrhythmias.    
The  mean  value  of  serum  magnesium  on  day-1  those   with arrhythmias  is  
1.58±0.26  those without  arrhythmias  is  2.10±0.4  (p<0.001). There  is  a   significant  
difference  in  the  mangesium   level  in  patient  with arrhythmias and without 
arrhythmias. 
 
 
 
 
0 
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1 
1.5 
2 
2.5 
MEAN SERUM MAGNESIUM LEVEL IN 
PATIENTSWITH ARRYTHMIA (N=30) 
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DAY 1 
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Figure 6 
TABLE 9: COMPARISON OF SERUM MAGNESIUM LEVEL IN PATIENTS WITH  
                     ARRYTHMIAS AND WITHOUT ARRYTHMIAS (DAY – 5) 
 
 
no.of 
cases 
serum Mg 
Day-5 
 
p- value 
Mean serum magnesium 
levels in patients with 
arrythmia 
 
30 
 
1.96+_0.32 
 
 
<0.001 
Mean serum Mg levels in 
patients without arrythmia 
 
30 
 
2.56+_0.48 
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 FIGURE : 7- Comparison of Serum magnesium levels in patients with Arrythmias and 
without arrhythmias (Day-5) 
 
MORTALITY: 
           In the above study of 60 patients, 12  patients died during their 5 days hospital 
course. 8 patients were died of ventricular tachycardia or ventricular fibrillation, 4 
patients died of cardiogenic shock. Mortality percentage was  20% .  
0 
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1 
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3 
Serum magnesium level in patients with 
arrythmia 
Serum magnesium levels in patients 
without arrythmia 
DAY 5 
DAY 5 
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Mr.DURAIRAJ 
50/M  
29762  
ACUTE EXTENSIVE ANTERIOR WALL MI 
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GANESAN 
80/M 
24824 
ACUTE  ANTEROSEPTAL MYOCARDIAL INFARCTION 
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PALPANDI 
37/M  
27729 
ACUTE INFERIOR WALL MYOCARDIAL INFARCTION 
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DISCUSSION 
                                                      DISCUSSION 
                      Magnesium ion has emerged as  a premier cardiovascular cation during the 
decade.    It has  been implicated  in  the pathogenesis  of acute  myocardial infarction  
and  complication  like  arrhythmias.    Magnesium  is  essential  for activation  of  ATP,  
which  maintains  the  sodium-potassium  pump  and  also because of calcium blocking 
action magnesium has been implicated in relation to arrhythmias after acute myocardial 
infarction. 
                        In the  study group  of  60 patients,  45 were  males and  15 were females 
with  a   male-female  ratio  of   4:1.     The  maximum  incidence   of  acute myocardial 
infarction was seen in the   6
th
  and 7th   decades. In the  present study  of  60  patients, 
the mean  serum magnesium  level on day-1 in all 60 patiens was 1.78±0.32  and the 
mean serum magnesium level on day-5 was 2.32±0.44. 
                          Abraham et al(13)    reviewed  magnesium level of  65 consecutive 
patients with an admission diagnosis of acute myocardial infarction. Serum magnesium 
concentration were  low in patient  who had AMI  (mean 1.70 mg/dl,  p<0.001) or  acute  
coronary insufficiency  (mean  1.61  mg/dl,  p<0.01),  but  not  in the control group or 
patients with non-cardiac chest pain (mean 1.91 mg/dl). 
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                     Singh A et al(60)    checked  serum magnesium levels of twenty  patients of 
acute myocardial infarction on the 1st  , 7th   and  12th   day of admission.  In all the 
cases, there was a significant fall of serum magnesium on the first day. Dimtruk[63]  in 
his series of 67 patients of ischemic  heart disease showed a  distinct reduction  of  
plasma magnesium  during the  first  3 days  following onset of disease, the level 
normalized by 15-25 days from onset of the disease. 
                      Sachdev   et   al(64)  (1978)   in   30   patients   of   myocardial  infarction 
determine the magnesiumlevels within 24  hours, 5th   and 8th   day and reportd as 
1.83±0.087   mgm%,   1.91±0.149   and   1.97±0.089   as   against   control   of 
2.44±0.162 mgm%.   The values  were statistically lower  on all the  three days showing a 
progressive rise. 
                       In  the   present  study,   the  serum   magnesium  level   on  day-1   was 
significant lower  in patients  with arrhythmias  than  those without  arrhythmia 
(p<0.001).  There  was an increase in  serum magnesium from Day-1  to Day-5 in both 
those with arrhythmias and those without arrhythmias. Ceremuzynski et  al (65)  assigned   
48  patients  with   acute  myocardial infarction over  24 hours infusion of  magnesium or 
placebo.  The incidence of ventricular   tachycardia    (3   or   more    consecutive   
premature   ventricular contraction at a  rate faster than  120/ min) recorded by  Holter 
monitoring was significantly   reduced   (p<0.001),  but   the   incidence   of   other  
ventricular  arrhythmias was not statistically different. 
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                      Raismusen   et  al(21)   randomized  273   patiens   with  suspected   acute 
myocardial  infarction  to   intravenous  magnesium  or  placebo.     There  is  a 
significant  decrease  in  the  ventricular arrhythmia  in  the  magnesium  group compared 
to placebo (p<0.05). Shecter   et  al (66)   randomized   103  patients   with   documented   
acute myocardial infarction to 48 hours infusion  of magnesium or placebo.  There is a 
significant decrease  in mortality (p<0.01).  There  was also a non-significant decrease in 
the number  of tachyarrhythmias requiring treatment (10/50)  in the magnesium group 
compared to control (24/53). 
                       Smith  et  al (67) randomized  400  patients  with  suspected AMI  to  a   
hours infusion of  magnesium sulphate or  placebo.  Two hundred  patients had confirmed  
acute   myocardial  infarction.     The  difference  in   mortality  and incidence of 
ventricular dysarrhtymia requiring  treatment between magnesium and placebo groups 
were not statistically singnificant. 
                        Abraham et  al[68]    randomly assigned  94  patients with acute  
myocardial infarction to  receive a  daily magnesium  bolus of  30 mmol  or placebo for  
3- days.   There was  no significant  difference in  mortality or  lethal arrhythmias 
between patients treated with magnesium and those treated with placebo. 
                         Felstedt   et   al(69)   randomized   298    patients   with   suspected   acute 
myocardial   infarction   to  24   hours   infusion   of   magnesium  or   placebo. 
Myocardial  infarction  was  documented  in  162 patients.    During  the  mean 
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observation period  of  245 days,  there was  no  difference in  the incidence  of 
tachyarrhythmias,  magnesium   infusion   was  associated   with  a   significant increase 
in bradyarrhythmias. Singh et al[70]  randomized  264 patients with  suspected acute 
myocardial infarction  to  magnesium, potassium,  10%  glucose  or  2%  glucose  
infusion. Myocardial   infarction   was   confirmed   in   228   patients.     Mortality   and 
ventricular tachycardia  or fibrillation  did not  differ significantly between  the 
magnesium group and placebo group. 
                      Morton  et  al(71) randomized  76  patients  to  receive  either magnesium 
infusion 0.38 mmol/l per kg every 12 hour or placebo over the first 36 hours of hospital, 
there was no difference in the incidence of ventricular tachycardia.  
                       Dyckner T et al (7)  during their 1½  years, 905 admission, 342 with acute 
myocardial   infarction,  563   other  diagnoses   ere   treated  in   the  CCU   on admission   
both   acute   myocardial   infarction   and   non   AMI   group  had significantly  lower  
serum  magnesium  level  than  as  reference  group.    The incidence of  serious 
ventricular  premature  beats, ventricular  tachycardia and ventricular   fibrillation    on   
admission    was   significantly   higher    in   the hypomagnesemic patients with acute 
myocardial infarction. 
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CONCLUSION 
                                                   CONCLUSION 
This study was carried out in 60 patients of acute myocardial infarction who are admitted  
to the ICCU of THANJAVUR MEDICAL COLLEGE THANJAVUR. 
1. The  male  to  female   ratio  in  the  study  group   was  4:1  and  the th 
maximum incidence of acute myocardial  infarction was seen in    6
th
   and  7
th
   decade. 
2. In the study Hindus were 80% and Muslim were 20%. 
3. In the  study, the  most common presentation  symptom was  chest pain 
4. and is  associated with  sweat in 25%  of patients  and 
5. breathlessness in  25% of patients and  6)  palpitation in 10%. 
7. In the study, the most common risk factor found was smoking followed 
by hypertension and diabetes. 
8. In the study group mean serum magnesium level  in 60 patients on day-1 is 1.78±0.32 
and on Day-5 is 2.32±0.44. 
9. In the  study  group mean  serum magnesium  level in  30 patients  with arrhythmia is 
1.58±0.30 on day-1 and 1.96±0.32 on day-5. 
10. In  the   study  group,  mean  serum   magnesium  level  in   30  patients 
without arrhythmia is 2.10±0.50 on day-1 and 2.56±0.48 on day-5 
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SUMMARY 
                                                        SUMMARY 
 
                           Coronary  artery disease  is a  major  cause of  morbidity  and mortality 
throughout the world.  Major cause of  death in coronary artery disease are due to 
complications like arrhythmias. 
                            In the present study, patients with acute myocardial infarction with low 
magnesium level are more prone  to develop ventricular arrhythmias compared 
to those  who are having  normal magnesium  levels.  Magnesium  replacement 
therapy in patients  with acute myocardial infarction  who is having low  serum 
magnesium level may reduce the incidence of arrhythmias. 
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.                                                  PROFORMA 
 
Name:                                 Sl. No.                                             Unit  
Age                                     IP No.                                              DOD  
DOA                                   Sex                                                  Occupation  
Final diagnosis                  religion  
Presenting Symptoms  
1.   Chest pain  
2.   Sweating  
3.   Dyspnoea  
4.   Orthopnea  
5.   PND  
6.   Palpitation  
7.   Others  
History of present illness  
1.   Chest pain  
* Location         
85 
* Nature                          Severity                                       Mild/ moderate/ severe  
                                       Character                                      Pricking/ throbbing  
                                                                                            Squeezing/ constricting  
                                                                                            Burning  
                                                                                            Agony/ other types  
* Onset – Hrs/ days back  
* Radiation  
* Continuous/ intermittent  
* Aggravating factor  
* Relieving factor                                           On taking rest  
                                                                        On taking drugs  
2.   Sweating  
3.   Dyspnea               Grade-I                  II              III        IV  
4.   Orthopnea  
5.   PND  
6.   Palpitation  
86 
     * Nature                                        Continuous/ racing of heart beats  
                                                      Other irregularities  
     * After excitement/ exercise/ drugs  
     * Periodicity  
     * Duration  
7.   Cough  
      * Dry/ productive  
      * Frothy sputum/ hemoptysis  
8.   Gastrointestinal symptoms  
      * Nausea  
      * Vomiting  
       * Dyspepsia/ heart burn/ indigestion  
       * Hiccoughs  
9.   Neurological symptoms:  
        * Convulsions  
        * Giddiness/ Fainting  
87 
      - Time of onset after pain  
      - Duration  
      - Consciousness  
10. Vascular symptoms  
      * Phlebitis  
      * Varicosity  
      * Claudication  
      * Raynaud’s phenomenon  
11. Endocrine symptoms  
      * Polyuria/ polydypsia/ polyphagia  
     * Excessive heat/ cold intolerance  
     * Any change in voice  
     * Change of hair distribution  
12. Miscellaneous  
     * Swelling of the limbs  
     * Abdominal distension  
88 
          * Visual disturbance  
III Past History  
1.   Angina  
         * Type  
         * Duration  
         * Frequency  
         * Any treatment taken  
2.   Myocardial infarction  
         * No. of attacks  
         * Details of admission and treatment  
3.   Hypertension  
         * Duration  
         * Treatment – not taken/ regular/ irregular  
         * Controlled/ Uncontrolled  
4.   Stroke/ TIA  
        * Treatment  
89 
5.   Diabetes mellitus  
            * Duration  
            * Treatment – Not treated/ regular/ irregular  
           * Controlled/ Uncontrolled  
6.   Renal diseases  
7.   Peptic ulcer  
8.   Rheumatic fever  
IV] Family History (Among-I, II, III Degree relatives)  
1.   IHD  
2.   Hypertension  
3.   Diabetes mellitus  
4.   Obesity  
5.   Cerebrovascular accidents  
6.   Sudden death  
7.   High cholesterol  
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8 
V]  Personal History  
1.   Socioeconomic status – Rich/ Middle/ Poor  
2.   Physical activity – Sedentary/ moderate exertion/ severe exertion  
3.   Marital status – Single/ married/ widow/er  
4.   Habits:  
             i)  Diet                    Vegetarian/ non-vegetarian/mixed  
            ii)Alcohol                 Type  
                                            Quantity  
                                            Frequency  
                                           Since how long  
          iii) Coffee/ tea/ other beverages  
                No. of cups per day ______ since _______ years  
          iv)Smoking: Beedies/ Cigarettes/ Others  
                                 Quantity __________ __________ __________  
                                 Duration __________ __________ __________  
         v)Tobacco/ Pan chewing  
91 
5.   Appetite  
6.   Bowels   
7.   Micturition  
8.   Sleep  
9.   Medication  
              i)   Corticosteroids  
             ii) Diuretics  
            iii)Others  
10. Drinking water source  
11. If female  
i)  Menstrual history  
ii)Obstetric history  
iii)Oral contraceptives  
VI} General Physical Examination 
1.   Built: Well built/ dwarf/ average  
           Height __________  
92 
2.   Nutrition: Normal/ Obese/ undernourished  
3.   State of consciousness  
4.   Cyanosis  
5.   Clubbing  
6.   Anemia   
7.   Edema  
8.   Xanthoma/ Xanthelasmas  
9.   Arcus senilis/ Juvenilis  
VII] Systemic Examination 
1.   Pulse  
* Rate  
* Rhythm  
* Character  
* Volume  
* Condition of vessel wall – normal/ thickened  
* Other peripheral pulses  
93 
2.   BP  
                       Upper limb  
                       Lower limb  
3.   JVP  
4.   Epigastric pulsation  
a)   Inspection  
-Shape of chest  
-Apical impulse  
-Other pulsations  
b)   Palpation  
-Apical impulse  
-Palpable heart sounds  
-Parasernal heave  
-Thrills  
-Other pulsations  
c)   Percussion  
94 
-Left border of the heart  
-Right border of the heart  
-Upper border of liver dullness  
-Any abnormal areas of dullness (Lt/ Rt I ics)  
d)   Auscultation:  
Heart sounds: Normal/ accentuated/ muffled/ slit   
* 1
st
 sound 
* 2
nd
 sound 
* 3
rd
 sound 
* 4
th
 sound 
Mitral area  
Tricuspid area  
Pulmonary area  
Aortic area:  
a)   Extra sound: Irregular rhythm/ triple rhythm/ galloop rhythm   
                           Murmur  
95 
                             Pericardial rub  
b)   Respiratory system  
c)   Gastrointestinal system  
d)   Genitourinary system  
VIII] Investigation  
1.Urine                  Albumin  
                            Sugar  
                            Micro  
2.    ECG at the time of admission  
3.   S.magnesium                 Sodium            Potassium             SGOT            SGPT  
1
st
 day 
5
th
 day 
IX] Course in Hospital  
Clinical parameters               ECG                    Management   
X] Final remarks and the summary of the case: 
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                                                       KEY TO MASTER CHART 
               
CVS............................Cardiovascular system 
RS...............................Respiratory system 
mm of Hg...................Millimeter of  mercury 
BP...............................Blood pressure 
Mg2+   ...........................Magnesium 
Na+  .............................Sodium 
K+  ...............................Potassium 
mg/dL.........................Milligram/ deciliter 
meq/l ..........................Milliequivalent liter 
VPCS..........................Ventricular premature contractions 
VT ..............................Ventricular tachycardia 
ECG............................Electrocardiogram 
CCF............................Congestive cardiac failure 
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                                                      MASTER CHART 
N
o. 
NAME A
G
E 
S
E
X 
IP 
No 
Symptom Signs/ 
BP 
ECG D
A
Y
S 
Mg Na 
 
k+ Complicat 
1 Jeyaraj 75 M 16184 Chest 
pain- 3 hr 
s1s2+ 
BP=120/80 
AWMI 1 
5 
1.51 
1.90 
136 3.8 VPCS 
recovered 
2 Jeevanandam 31 M 17131 chest 
pain-6hrs 
s1s2+ 
BP=110/70 
ASMI 1 
5 
1.94 
2.40 
138 4.0 recovered 
3 Kumeresan 58 M 17182 chest pain 
4 hrs 
S1S2+ 
BP=130/80 
IWMI 1 
5 
1.87 
2.12 
136 3.8 VPCs 
recovered 
4 Kendiyammal 80 F 17462 chestpain
-6 hrs 
S1S2+ 
BP=120/70 
IWMI 1 
5 
2.12 
2.60 
140 4.0 VPCs 
recovered 
5 Durairaj 50 M 17667 chestpain
- 2 hrs 
s1s2+ 
BP=80/50 
AWMI 1 
5 
1.12 143 3.9 VT,died 
6 Palpandi 37 M 17929 chestpain
- 8 hrs 
s1s2+ 
BP=130/70 
IWMI 1 
5 
1.82 
2.10 
147 4.5 VPCs 
recovered 
7 Kumeresan 38 M 18182 chestpain
- 4 hrs 
s1s2+ 
BP=110/70 
IWMI 1 
5 
1.62 
1.82 
143 4.2 recovered 
8 Kaliyamoorthi 45 M 18289 chestpain
-10 hrs 
s1s2+ ASMI 1 
5 
1.92 
2.86 
138 4.5 SVT 
recovered 
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No
. 
NAME A
G
E 
S
E
X 
IP 
No 
Symptom Signs/ 
BP 
ECG D
A
Y
S 
Mg Na 
 
k+ Complicat 
9 Mani 65 M 18362 chestpain
-3hrs 
s1s2+ 
BP=110/70 
IWMI 1 
5 
2.12 
2.34 
146 4.7 VPCs 
recovered 
10 Raj 68 M 18409 chestpain 
-6 hrs 
s1s2+ 
BP=140/80 
AWMI 1 
5 
1.45 
1.91 
142 4.9 recovered 
11 Ganesan 39 M 18824 chestpain
-8 hrs 
s1s2+ 
BP=?? 
AWMI 1 
5 
1.09 146 4.0 VT 
,DIED 
12 Ayyappan 70 M 19412 chestpain 
-4 hrs 
s1s2+ 
BP=100/80 
IWMI 1 
5 
1.45 
1.68 
138 4.8 recovered 
13 Mathialagan 65 M 18942 chestpain 
-2 hrs 
s1s2+ 
BP=100/80 
ASMI 1 
5 
1.92 
2.18 
145 4.2 recovered 
14 Rajkumar 58 M 20241 chestpain
-6 hrs 
s1s2+ 
BP=90/60 
AWMI 1 
5 
1.39 
 
140 4.8 VT 
died 
15 Krishnamoorthi 62 M 20542 chestpain
-8hrs 
s1s2+ 
BP=130/80 
IWMI 1 
5 
1.98 
2.45 
134 4.0 recovered 
16 Valliyammal 82 F 20914 chestpain
-4hrs 
s1s2+ 
BP=120/80 
ASMI 1 
5 
2.18 
2.52 
142 4.2 recovered 
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No
. 
NAME A
G
E 
S
E
X 
IP 
No 
Symptom Signs/ 
BP 
ECG D
A
Y
S 
Mg Na 
 
k+ Complicat 
17 Muthurasi 65 F 21847 chestpain
=8hrs 
s1s2+ 
BP=160/70 
AWMI 1 
5 
2.12 
2.56 
148 4.5 recovered 
18 Basheer 52 M 21997 chestpain
-10 hrs 
s1s2+ 
BP=70/50 
AWMI 1 
5 
1.18 
1.65 
142 4.8 Cardioge
nic shock 
19 Senthilkumar 48 M 22121 chestpain
-2hrs 
s1s2+ 
BP=150/70 
IWMI 1 
5 
1.68 
1.82 
145 3.9 recovered 
20 Tamilarasi 68  F 22456 chestpain
-4 hrs 
s1s2+ 
BP=90/70 
IWMI 1 
5 
1.42 
1.78 
139 4.2 VT 
recovered 
21 Kumaran 69 M 22679 chestpain
-3hrs 
s1s2+ 
BP=110/70 
ASMI 1 
5 
1.83 
2.18 
141 4.5 VPCs 
recovered 
22 Muhammed 53 M 22828 chestpain 
-4 hrs 
s1s2+ 
BP=150/80 
ASMI 1 
5 
1.95 
2.12 
148 5.0 recovered 
23 Selvi 68 F 23167 chestpain
-8 hrs 
s1s2+ 
BP=130/80 
AWMI 1 
5 
2.15 
2.34 
139 4.9 VPCs 
recoverd 
24 Stalin 72 M 25826 chestpain
-4 hrs 
s1s2+ 
BP=140/90 
AWMI 1 
5 
2.02 
2.42 
145 5.0 recovered 
 
 
100 
 No
. 
NAME A
G
E 
S
E
X 
IP 
No 
Symptom Signs/ 
BP 
ECG D
A
Y
S 
Mg Na 
 
k+ Complicat 
25 Muruganantham 48 M 26212 chestpain
-8 hrs 
s1s2+ 
BP=90/60 
AWMI 1 
5 
1.42 
1.84 
145 3.8 LVF 
recovered 
26 Kumari 65 F 26574 chestpain
-6 hrs 
s1s2+ 
BP=160/90 
IWMI 1 
5 
1.56 
2.28 
146 4.2 VPCs  
recoverd 
27 Veeraiyan 80 M 26589 chestpain
-5 hrs 
s1s2+ 
BP=180/90 
ASMI 1 
5 
1.82 
1.98 
149 4.8 VPCs 
recovered 
28 Jahangir 70 M 26987 chestpain
-4hrs 
s1s2+ 
BP=140/80 
AWMI 1 
5 
2.09 
2.43 
143 3.9 recovered 
29 Rajendhiran 60  M 27217 chestpain 
-2 hrs 
s1s2+ 
BP=120/70 
ASMI 1 
5 
1.22 
1.58 
134 4.0 VPCS 
Died 
30 Amina 80  F 27861 chestpain
-5hrs 
s1s2+ 
BP=100/70 
AWMI 1 
5 
1.76 
1.98 
136 4.2 recovered 
31 Shahul 67 M 27921 chestpain
-7 hrs 
s1s2+ 
BP=160/90 
ASMI 1 
5 
1.23 
1.67 
145 4.0 VPCs  
recoverd 
32 Keerthana 78  F 27998 chestpain
-4hrs 
s1s2+ 
BP=?? 
AWMI 1 
5 
1.13 
 
138 4.5 recovered 
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 No
. 
NAME A
G
E 
S
E
X 
IP 
No 
Symptom Signs/ 
BP 
ECG D
A
Y
S 
Mg Na 
 
k+ Complicat 
33 Rasu 80 M 28714 chestpain
-6 hrs 
s1s2+ 
BP=?? 
ASMI 1 
5 
1.23 
 
135 3.9 VT 
died 
34 Ramkumar 40 M 28843 chestpain
-3 hrs 
s1s2+ 
BP=160/90 
IWMI 1 
5 
1.46 
2.48 
137 5.2 VPCs  
recoverd 
35 Muhammed 60 M 29214 chestpain
-5 hrs 
s1s2+ 
BP=150/90 
AWMI 1 
5 
1.52 
2.34 
141 3.8 SVT 
recovered 
36 Abdulla 75 M 30672 chestpain
-9hrs 
s1s2+ 
BP=140/80 
AWMI 1 
5 
2.19 
2.65 
133 3.6 recovered 
37 Jayakumar 65  M 30754 chestpain 
-7 hrs 
s1s2+ 
BP=90/60 
IWMI 1 
5 
1.18 
 
145 4.7 VPCS 
Died 
38 Thangaraj 70  M 30761 chestpain
-1hrs 
s1s2+ 
BP=130/80 
AWMI 1 
5 
1.66 
1.95 
143 5.0 VPCs 
recovered 
39 Suresh 48 M 30858 chestpain
-4 hrs 
s1s2+ 
BP=150/90 
AWMI 1 
5 
1.34 
1.54 
138 4.4 recoverd 
40 Ravi 58  M 30992 chestpain
-6hrs 
s1s2+ 
BP=?? 
AWMI 1 
5 
1.45 
 
138 4.5 VT died 
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No
. 
NAME A
G
E 
S
E
X 
IP 
No 
Symptom Signs/ 
BP 
ECG D
A
Y
S 
Mg Na 
 
k+ Complicat 
41 Kiruthiga 70 F 31714 chestpain
-4 hrs 
s1s2+ 
BP=120/80 
IWMI 1 
5 
1.93 
2.74 
139 4.9 recovered 
42 Ramu 40 M 32543 chestpain
-1 hrs 
s1s2+ 
BP=100/70 
IWMI 1 
5 
1.76 
1.98 
142 3.9 VT  
recoverd 
43 Noorjahan 50 F 32594 chestpain
-4 hrs 
s1s2+ 
BP=110/60 
AWMI 1 
5 
1.72 
2.68 
149 3.7 recovered 
44 Alamina 65 F 32672 chestpain
-2hrs 
s1s2+ 
BP=80/60 
IWMI 1 
5 
1.27 
 
136 4.9 VPCs  
Died 
45 Jayaraman 35  M 32765 chestpain 
-6 hrs 
s1s2+ 
BP=100/60 
AWMI 1 
5 
1.79 
1.99 
135 4.2 Recovere
d 
46 Suhakar 56  M 33632 chestpain
-9hrs 
s1s2+ 
BP=110/80 
ASMI 1 
5 
1.86 
2.49 
142 4.0 VT  
recovered 
47 Revathi 50 F 33876 chestpain
-3 hrs 
s1s2+ 
BP=140/90 
AWMI 1 
5 
1.34 
1.54 
140 4.5 recoverd 
48 Sukumar 38  M 34543 chestpain
-2hrs 
s1s2+ 
BP=150/80 
ASMI 1 
5 
1.75 
2.23 
137 3.9 VPCs  
recovered 
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No
. 
NAME A
G
E 
S
E
X 
IP 
No 
Symptom Signs/ 
BP 
ECG D
A
Y
S 
Mg Na 
 
k+ Complicat 
49 Appusamy 68 M 35543 chestpain
-7 hrs 
s1s2+ 
BP=120/80 
IWMI 1 
5 
1.43 
1.84 
138 4.8 Recovere
d 
50 Rubina 50 F 35987 chestpain
-1 hrs 
s1s2+ 
BP=150/80 
AWMI 1 
5 
1.76 
2.18 
135 4.9 Recovere
d 
51 Riyaz 50 M 36345 chestpain
-3 hrs 
s1s2+ 
BP=110/70 
AWMI 1 
5 
1.82 
2.02 
144 3.7 VPCs 
recovered 
52 Jayakumar 65 M 37765 chestpain
-6hrs 
s1s2+ 
BP=90/60 
AWMI 1 
5 
1.19 
1.65 
145 3.9 VPCs 
died 
53 surya kumar 45  M 37675 chestpain 
-4 hrs 
s1s2+ 
BP=100/60 
AWMI 1 
5 
2.23 
2.65 
142 4.1 recovered 
54 Thangamuthu 35  M 37776 chestpain
-5hrs 
s1s2+ 
BP=?? 
ASMI 1 
5 
1.10 
 
140 5.3 VT DIED 
55 Soundharya 58 F 38764 chestpain
-2 hrs 
s1s2+ 
BP=140/90 
IWMI 1 
5 
1.74 
1.96 
139 4.6 recoverd 
56 Krishnamoorthi 78  M 38742 chestpain
-4hrs 
s1s2+ 
BP=90/60 
IWMI 1 
5 
1.94 
 
135 3.9 VPCs 
died 
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No
. 
NAME A
G
E 
S
E
X 
IP 
No 
Symptom Signs/ 
BP 
ECG D
A
Y
S 
Mg Na 
 
k+ Complicat 
57 Arumugham 70 M 39456 chestpain
-3 hrs 
s1s2+ 
BP=110/70 
ASMI 1 
5 
1.93 
2.64 
138 4.1 recovered 
58 Remya 60 F 40764 chestpain
-6 hrs 
s1s2+ 
BP=140/90 
IWMI 1 
5 
1.76 
2.08 
142 5.1 VPCs  
recoverd 
59 Annadurai 67 M 44685 chestpain
-9 hrs 
s1s2+ 
BP=80/60 
AWMI 1 
 
1.51 145 4.9 VT 
Died 
60 Krishnan 54 M 45465 chestpain
-2hrs 
s1s2+ 
BP=80/50 
AWMI 1 
5 
1.89 
2.45 
143 3.8 Cardioge
nic shock 
recovered 
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